2024-07-08 12:33:33
In recent years, the emergence of new type 2 diabetes drugs, known as GLP-1 receptor agonists, has caused great interest for their ability to aid weight loss. Among them, Wegovy (semaglutide) has stood out for its effectiveness in this area, receiving approval for the treatment of obesity in 2023.
How do cancer drugs work to lose weight?
GLP-1 agonists mimic the action of the natural hormone that regulates appetite and insulin production. By acting on the brain, these drugs increase the feeling of satiety, leading to a reduction in food intake and, therefore, weight loss.
What do the studies say?
Clinical trials have shown that Wegovy and other GLP-1 agonists can produce significant weight loss in overweight or obese adults, especially when combined with a healthy diet and physical exercise.
Are they safe?
These drugs are generally considered safe when used as directed. However, like any other drug, they can have side effects, such as nausea, vomiting, diarrhea, and constipation. In rare cases, more serious side effects, such as pancreatitis and gallbladder problems, have been observed.
Who are they referring to?
Wegovy and other GLP-1 agonists are not for everyone. They are approved for the treatment of adults with:
Obesity (BMI ≥ 30)
Overweight (BMI ≥ 27) includes at least one weight condition, such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea.
It is important to consult a doctor to decide if these drugs are right for you.
Remember that GLP-1 agonists are not a magic solution for weight loss. To achieve sustainable results, it is important to adopt a healthy lifestyle that includes a balanced diet and regular exercise.
GLP-1 agonists such as Wegovy represent a promising new tool for the treatment of obesity and overweight. However, it is important to use them under the supervision of a doctor and combine them with lifestyle changes for optimal, long-lasting results.
References
Spanish Agency for Medicines and Health Products (AEMPS): aemps.gob.es/
Spanish Diabetes Federation (FEDE): fedesp.es/portal/portada/
Spanish Society of Gastroenterology and Nutrition (SEE): ri.org/
Created by:
08/07/2024 14:07
This information should not replace a doctor’s opinion. If you have any questions, consult with professionals.
#Wegovy #cancer #drugs #lose #weight